chrisvoncsefalvay/vaers-outcomes huggingface dataset:
received first shot 2/14/21, never received 2nd; This case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine (1st dose received on 14th February 2021).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable. The patient received first shot back on 14th February 2021, with everything going on he/she had never received the second shot, therefore till the time of reporting the patient had not received their 2nd dose which led to incomplete course of vaccination. The reporter inquired if it was too late or do they have to get the both doses over again.
After 30 minutes after vaccination, patient started to feel faint, fingers started to tingle and SOB reported by patient in the front of the store as he was going home. Patient was sat in chair and pharmacy was contacted of the emergency. Pharmacist rushed to front with epi-pen but patient stated that his symptoms had left and that he was ok. Patient denied tongue swelling, SOB, throat swelling, loss of feeling in limbs. Patient reported feeling fine and needed to sit down. 911 was immediately called for further evaluation. They arrived quickly and left with patient to evaluate him.
At 11:51 AM, RN administered 0.1cc dose of Jynneos vaccine Lot # FDP000014 exp date 11/17/2022 via intradermal route to right arm to Patient, age 25 and a wheal was not produced. RN notified clinic lead nurse PHN regarding incident and per clinical guidance was instructed to give a 2nd dose. Patient requested to get 2nd dose on right arm. Educated patient that because no wheal was produced, a repeat dose must be placed to the other arm or 2 inches away from the 1st dose. Patient verbalized understanding. RN re-administered another dose of 0.1cc of Jynneos Lot #  FDP000014 exp date 11/17/2022 left arm and a wheal was produced. Patient was educated to observe for adverse reactions.
immediate lip tingling no swelling, tingling in throat, EMS activated resulting in 30 min observation
Narrative: 78yoM admitted for multifocal pneumonia on 1/3/2023. Diagnosed with COVID on 12/23/2022. Per H&P, Patient feeling better after COVID treatment, but then developed cough with sputum production, fever, chills and SOB. Treated with supportive oxygen, Rocephin, and azithromycin.
Patient appear to have seizure just after receiving the vaccination.  After apparent seizure or loss of consciousness patient appear weak and had a hard time answering questions.  911 was called and patient transported for medical care.
Narrative:  Hospitalized for AMS and hypoglycemia; found to be COVID-positive on admission. Patient fully vaccinated had previous positive test at SNF~ 14 days prior to admission. (note: vaccination information incomplete as patient was vaccinated outside clinic)
Approximately 7 hours after receiving the vaccine experienced chills and fever accompanied with headache for 36 hours. Severe body aches started 12 hours post vaccine
thrombocytopenia  I received my Covid vaccine at the beginning of April and near the end of April I found out I was pregnant. During my 12 week blood test, it was found that my platelets were low.  I actually didn?t associate the correspondence between the low platelets and my vaccine until I was reading a peer reviewed article regarding this being a potential side effect of the Pfizer vaccine.
Symptoms: Stiff neck, severe headache, fever of 101.4, fatigue.  Treatment: Outpatient ER Visit for 2 IV's and Toradol for pain and inflammation.
Pt reported she noticed a blister on 8-14-11 and it popped today (8/15/11). Denies itching, pain or fever. No HA, nausea, dizziness. Tx - BACTROBAN and dressing applied.
9 hours after the shot I started to feel really groggy and sore with my left arm hurting. 12 hours in I started to feel like I had a fever so i checked it and it was 102 degree F, I was also unable to pick my left arm up due to the pain and my whole body hurt a lot. 13 hours in at about 10 pm that night I started full-body shaking violently and needed help from my parents into my room because I could not walk because my legs were wobbling so much. I felt lightheaded and the shaking continued for about 20 minutes. During this time I checked my temp again and it was 105 degrees F. Once the shaking stopped the fever and intense pain continued until 2 am when it dropped down to 102 degrees F and I was able to fall asleep. The next morning I woke at 8am with a temp of 100 degree F with the same all-over-body pain that lasted all day but the fever dropped until that night. That night it came back at 100 degrees F.  This cycle lasted from when I got my shot on the 1st until 4th when the fever stopped. The pain has subsided around the 6th. But I am currently still having pain in my left shoulder where I got my shot today on the 8th.
Vaccinee rec'd first dose lt deltoid on 19SEP90; Raised erythematous rash w/pruritus appeared on 22SEP90 on lt arm above lt elbow & below inject site, & on front of lt knee; Itching responds to OTC Benadryl cream; Rash progressed to rt arm;
Received vaccine in Left Deltoid on January 6, 2021; awoke with left lower quadrant breast pain on 1/9/21.  There has been consistent in pain (consistent soreness) ,  in left breast since January 6. There is a dilated vein or blood vessel noted in the left breast I can feel an indurated or firm small bump under the dilated blood vessel.  There is also pain in the right breast, but there is not as painful.
vaccine recipient was 12 years old at the time of vaccination, but received the pediatric formulation in error.
Dose #1: Mild to mod myalgias and arthralgias-localized. Onset 24-48 hours after dose. Dose #2: Moderate to severe generalized myalgias and arthralgias; subjective fever; poor concentration. Onset 48 hrs after 2nd dose; lasted 4-5 dys.
Initial and follow up information has been received from a physician and a health care professional concerning a 13 year old female patient who on 15-MAR-2007 at 04:30 PM was vaccinated IM with a first dose of GARDASIL vaccine, lot #654510/0962F. Concomitant therapy included ADACEL, MENACTRA and tuberculin purified protein derivative. On 19-MAR-2007 the patient developed an off cycle additional menstrual cycle with a heavy flow. Unspecified medical attention was sought. The patient's outcome was unknown. Additional information has been requested. This is in follow-up to report (s) previously submitted on 4/13/2007. Additional information has been requested.
Both of my daughters are experiencing all over body rash involving hives that come and go all day long. Patient's was so bad and painful on 1/30/22 that she called MD and was prescribed 4 days of prednisone, Zyrtec and famotidine, which helped while taking them, but after treatment was done, all symptoms have returned.
severe ha, n/v, low grade fever with chills, sore arm,  stiff and sore joints  Narrative:   Other Relevant History:
This spontaneous report as received from a nurse refers to unknown patients of unknown age. On an unknown date since 10-JUN-2014, patients was vaccinated with doses PNEUMOVAX 23 (lot#, expiration date, dose, route not reported) which were improperly stored. No adverse effects reported. This is one of the several reports from the same source. Additional information is not expected.
2 years old patient / received by mistake a dose of Bexsero; This case was reported by a nurse via call center representative and described the occurrence of wrong vaccine administered in a 2-year-old patient who received Men B NVS (Bexsero) (batch number ABXA93AA, expiry date 28th February 2022) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 11th January 2021, the patient received Bexsero and Bexsero Pre-Filled Syringe Device. On an unknown date, unknown after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced wrong vaccine administered. On an unknown date, the outcome of the wrong vaccine administered was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: Nurse reported a patient who received by mistake a dose of Bexsero, they were trying to administer Menactra which led to wrong vaccine administered.  The vaccine was administered on the same day as reported it. The reporter consented to follow up.
PATIENT REPORTED TO PHARMACY 4/23 COMPLAIN OF NAUSEA, HEADACHE, FATIGUE, AND SWELLING AND PAIN AT THE INJECTION SITE. UPON INSPECTION, I NOTED SWELLING AND REDNESS THE SIZE OF A PALM AND PURPLE COLORED BRUISING UNDERNEATH INJECTION SITE SPANNING THE LENGTH OF HER ARM. 4/24 PATIENT STATING REDUCED HEADACHE AND FATIGUE, BUT ARM SYMPTOMS REMAINED. PATIENT ALSO NOTED TINGLING IN HER FINGERS AND DIFFCULTY MOVING FINGERS. AT THIS POINT I ADVISED HER TO GO TO ER
Jaw locked up on right side, could not open mouth.  Resolved in a half hour.
Vaccinated at 1100 was feeling fine until 1400 same day (6/7) started to experience L sided weakness and stroke like symptoms. Take to ED and admitted to hospital.
Patient has since discovered she's pregnant - was on depo, menstrual irregular.  Very possibly pregnant on day of immunization.
Intense lethargy; tightness in chest; Some difficulty in breathing upon exertion; Muscle soreness at the site; Severe chills; extreme shaking; Could Barely walk; This case was reported by a consumer and described the occurrence of injection site muscle pain in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 22nd December 2020, the patient received Shingrix. In December 2020, less than a day after receiving Shingrix, the patient experienced chills, tremor and walking difficulty. On 22nd December 2020, the patient experienced injection site muscle pain. On 23rd December 2020, the patient experienced lethargy, chest tightness and exertional dyspnea. On an unknown date, the outcome of the injection site muscle pain, chills, tremor, walking difficulty, lethargy, chest tightness and exertional dyspnea were unknown.   It was unknown if the reporter considered the injection site muscle pain, chills, tremor, walking difficulty, lethargy, chest tightness and exertional dyspnea to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The patient experienced muscle soreness at the site but not much else.  Also experienced severe chills that she could barely walk and had difficulty opening Advil bottle due to extreme shaking.  She had intense lethargy on 23rd December 2020.  Symptoms included tightness in chest and some difficulty in breathing upon exertion. This case had been linked with US2020AMR256527 reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR256527:Husband's case
I received my Covid-19 vaccine on 02/01/2023. On 02/02/2023 I woke up with a swollen arm. I started feeling feverish. I felt as if I was on fire from the inside out. I started to feel real sleepy. Gradually my sore throat turned into not being able to talk and lack of appetite. I reached out to my doctor. I am still in the process of getting information after speaking to my doctor.
w/in 3 hrs pvax began having a sz & was hosp & kept in ICU for first noc;
tired; restless night of sleeping/poor sleep; This is a spontaneous report from a non-contactable consumer. An 81-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number EL3247 and expiry date unknown) via unspecified route of administration on 22Jan2021 at single dose for Covid-19 immunization in a hospital. The patient's medical history and concomitant medications were not reported. The patient was not diagnosed with COVID-19 prior to vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced having a restless night of sleeping the night of having gotten the COVID-19 vaccine (22Jan2021). The patient was tired the next day (23Jan2021) but was unsure if it was related to poor sleep itself or as a side effect of the vaccine, otherwise she felt good and did not seek any medical attention. The patient has not been tested for COVID-19 since the vaccination. The patient did not receive treatment due to the events. The outcome of the events restless night of sleeping, tired was recovered. The reporter considered the event non-serious; did not results in death; not life threatening; did not caused/prolonged hospitalization, not disabling/incapacitating, no congenital anomaly/birth defect.  No follow-up attempts are possible. No further information is expected.
Student came in today right upper arm swollen and tender to touch, warm pack applied T 98.1, Motrin 200mg 10/05/2005.
This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE PRURITUS (itching at the injection site that was about an inch in circumference), VACCINATION SITE SWELLING (Sweling at the injection site that was about an inch in circumference) and VACCINATION SITE ERYTHEMA (Redness at the injection site that was about an inch in circumference) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. No Medical History information was reported. On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (itching at the injection site that was about an inch in circumference), VACCINATION SITE SWELLING (Sweling at the injection site that was about an inch in circumference) and VACCINATION SITE ERYTHEMA (Redness at the injection site that was about an inch in circumference). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) on 20-Jan-2021 for Adverse event following immunisation, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PRURITUS (itching at the injection site that was about an inch in circumference), VACCINATION SITE SWELLING (Sweling at the injection site that was about an inch in circumference) and VACCINATION SITE ERYTHEMA (Redness at the injection site that was about an inch in circumference) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. Patient reported events occurred approximately a week before his call on 27Jan2021; Sender's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the events, a causal relationship cannot be excluded.
Patients upper arm is very red, hot, swollen and painful. From under arm to elbow. Instructed patient to cool compress arm take BENADRYL and we will follow up.
I received the second dose on April 6, 2021. After the shot I felt nauseous and have sever left arm pain. On April 16,2021 I went to  MD as I was still not feeling well. There I was told I had a ?left shoulder impingement secondary to vaccine. On April 22, 2021 I went to the emergency department at hospital where I was told I have permanent nerve damage from the vaccine injection. I am still unable to fully use my arm as it hurts to even hold my cell phone and type on a computer.
Patient completed Pfizer COVID-19 vaccine series on 2/9/21. Patient presented to reporting hospital ER on 9/19/21, 9/22/21, and 9/27/21 with worsening of symptoms of COVID.  Admitted 9/27/21 and currently inpatient at facility. Symptoms include diarrhea, cough, loss of taste and smell, vomiting, dizziness, chest pain, and shortness of breath.  Patient was ultimately admitted for COVID pneumonia with mild bilateral opacities.
Pt. developed red, swollen arm at vaccination site and urticaria all over his body.
Headache Nausea Fatigue Started about 8 or 9 hours after
Patient reported feeling fatigued and drained of energy. She also reports a 3 inch by 3 inch area around the injection site that is swollen, red, (she says like a bug bite) and itchy.
On the day of the vaccine I had usual arm soreness. For about 1 hour in the evening I had chills and felt nauseous. I felt fine after that. One week later I woke up and my entire arm was very sore. I thought I slept on it wrong. The pain radiated down my entire arm. Later in the morning, my wrist was incredibly sore and throbbing with pain.  Later that evening I started to rub my arm at the injection site and felt a large, hard bump. I looked at my arm and noticed a red rash in the area as well. I called the Health Dept (who gave the vaccine) and they said to ice it and take advil, which I did. The next day the swelling went down a little bit, but the rash area is much bigger & is not hot to the touch. Today is day 3 of this & the rash & heat are the same. It is less painful than the first day of this reaction.  I googled this and I am seeing people call this "COVID arm." It does not itch though.
A entertainment reporter reported referring to a male patient of unknown age. The patient's medical history, concurrent condition and concomitant medication were unknown. On an unknown date, the patient was vaccinated with a dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (manufacturer unknown) (dose, route, lot# and expiration date unknown) for prophylaxis. Subsequently on an unknown date, the patient developed autism. The patient's father believed his autistic son "changed overnight" after being administered the vaccine and linked thimerosal to the developed of the condition. The outcome of the event was unknown. Upon internal review, autism was considered as medically significant. Additional information has been requested.
Same as with second dose.  Intense shaking (not just chills) akin to having Parkinson?s (twitching, etc) started at 1:15 and lasted until around 4pm.  Intense sinus headaches which pain meds didn?t help for the next 24 hours.  It has now day four and I am still experiencing fever spikes, sore arm and brain fuzziness.  On the day after the shot I could barely get out of bed and when I did I had to hold onto the wall to stop falling over.  I would say that the symptoms this time lasted about 24 hours longer than dose 2.
A non-serious spontaneous report of NOSE BLEED was received from a physician concerning a seven-year-old male subsequent to FLUMIST.  The patient's medical history has not been reported.  The patient "was also taking SINGULAIR".  The patient received FLUMIST vaccine on 12-Aug-2008.  On 17-Aug-2008, the patient started having nose bleeds which continued over four days.  The patient's parent indicated that there was a total of ten nose bleeding episodes during that period of time.  The outcome of the event is unknown.
Asphyxiation; like had a heart attack; Blood pressure was 150/90; sever allergic reaction; lethargic; Arrhythmia; Fast heartbeat; A spontaneous report was received from a 46 year old female who received Moderna's COVID-19 vaccine (mRNA-1273) and who experienced asphyxiation, fast heartbeat, lethargy, blood pressure 150/90, arrhythmia and a heart attack like episode.  The consumer received the first of the two planned doses of mRNA-1273 on 05-FEB-2021 (Batch #: 028L20A) intramuscularly for prophylaxis of COVID-19 infection.  On 06-FEB-2021, Patient experienced fast heartbeat.   On 07-FEB-2021, she became lethargic.     On 08-FEB-2021, she called the EMT due to complaints of rapid heartbeat as if she was experiencing arrhythmia. The patient stated that her blood pressure was 150/90, as well as, she had asphyxiation and felt like she had a heart attack.   No treatment information was provided. Action taken with mRNA-1273 in response to the events was unknown.  The patient's medical history was not provided. No relevant concomitant medications were reported.  The outcome of the events was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Patient received both vaccines in the right deltoid as he requested due to his left arm giving him problems. He experienced pain in the arm, hot to the touch and red lines from site. Was unsure if he ran a fever as he does not have thermometer. Patient was instructed to go to ED 10/28/16.
This spontaneous report has been received from registered nurse referring to an unspecified number of patients of unknown ages and genders. Medical history, concurrent condition, drug reactions and allergies were not reported. On an unknown date, the patients were vaccinated with improperly stored doses of GARDASIL 9 (lot # K026246 expiration date: 28-JAN-2017 and lot # L014415 expiration date: 25-JUL-2017) (dose, indication, route of administration were unspecified). Concomitant therapies were not provided. No adverse symptoms were reported. No product quality complaint was involved. This is one of several reports from the same source (MARRS: 1511USA014672; 1511USA014713; 1511USA014712; 1511USA014715). Additional information has been requested.
Initial information received on 03-Dec-2018 regarding an unsolicited valid non-serious case received from a physician. This case involves a 3 years old patient who received vaccine TYPHIM VI (lot N1K911M and expiration date 27-Oct-2019) via intramuscular route in the left arm on 01-Dec-2018 that underwent a three day shipping excursion. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. The patient received no other concomitant vaccines. It was a case of actual medication error due to incorrect product storage. It was not reported if the patient had any adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. List of documents held by sender: none.
I had fatigue on the first day that continued to the next day. I then had body aches.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. There was no information about the patient's concomitant medications, allergies and pertinent medical history reported. On an unknown date, the patient was vaccinated with a dose of improperly stored ZOSTAVAX lot# reported as M041510, expiry date 27-JUL-2017 (dose, route of administration and anatomical location were not reported). It was stored in the temperature in the range of 5 Fahrenheit degrees to 14 Fahrenheit degrees for 15 minutes and in the range of 14 Fahrenheit degrees to 46 Fahrenheit degrees for 1 hour and 45 minutes. There was no previous temperature excursion. The digital data logger was involved. No adverse effects were reported. Additional information is not expected as no consent for follow up was given.